Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy
  1. Home
  2. Publications
  3. Supplementary Table S1 from p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy

Supplementary Table S1 from p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy

Authors:
  • DFDouglas V. Faget
    Douglas V. Faget
  • XLXianmin Luo
    Xianmin Luo
  • MIMatthew J. Inkman
    Matthew J. Inkman
  • QRQihao Ren
    Qihao Ren
  • XSXinming Su
    Xinming Su
  • KDKai Ding
    Kai Ding
  • MWMichael R. Waters
    Michael R. Waters
  • GRGanesh Kumar Raut
    Ganesh Kumar Raut
  • GPGaurav Pandey
    Gaurav Pandey
  • PDPaarth B. Dodhiawala
    Paarth B. Dodhiawala
  • RRRenata Ramalho-Oliveira
    Renata Ramalho-Oliveira
  • JYJiayu Ye
    Jiayu Ye

Open Access
Publisher website
Google Scholar
  • 2 June 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2159-8290.23283195
Abstract
Table containing all of our reagents
Keywords
  • CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.